Dermal Diagnostics Limited - Accounts to registrar (filleted) - small 17.3

REGISTERED NUMBER: 06795555 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2017

for

Dermal Diagnostics Limited

Page

Company Information

1

Abridged Balance Sheet

2

Notes to the Financial Statements

4

Chartered Accountants' Report

7

DIRECTORS:

Dr D F H Chowdhury

B Timol

REGISTERED OFFICE:

Advanced Technology Innovation Centre

Loughborough University Science &

Enterprise Parks, 5 Oakwood Drive

Loughborough

Leicestershire

LE11 3QF

REGISTERED NUMBER:

06795555 (England and Wales)

ACCOUNTANTS:

HSKS Greenhalgh

Chartered Accountants

18 St Christopher's Way

Pride Park

Derby

DE24 8JY

FIXED ASSETS

Intangible assets

4

128,788

84,246

Tangible assets

5

7,356

5,342

136,144

89,588

CURRENT ASSETS

Debtors

40,029

(137,068

)

Cash at bank

5,691,965

6,534,591

5,731,994

6,397,523

CREDITORS

Amounts falling due within one year

7,601,953

6,865,359

NET CURRENT LIABILITIES

(1,869,959

)

(467,836

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(1,733,815

)

(378,248

)

CREDITORS

Amounts falling due after more than one year

950,000

975,000

NET LIABILITIES

(2,683,815

)

(1,353,248

)

CAPITAL AND RESERVES

Called up share capital

6

10,000

10,000

Share premium

315,500

315,500

Retained earnings

(3,009,315

)

(1,678,748

)

SHAREHOLDERS' FUNDS

(2,683,815

)

(1,353,248

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 March 2017 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 29 December 2017 and were signed on its behalf by:

Dr D F H Chowdhury - Director

1.	STATUTORY INFORMATION

Dermal Diagnostics Limited is a private company, limited by shares , registered in England and Wales.

The company's registered number and registered office address can be found on the Company

Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are

measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over there estimated useful life of between 6 to 20

years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement,

except to the extent that it relates to items recognised in other comprehensive income or directly in

equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been

enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at

the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods

different from those in which they are recognised in financial statements. Deferred tax is measured

using tax rates and laws that have been enacted or substantively enacted by the year end and that are

expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable

that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at

the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of

exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at

the operating result.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the

period of the lease.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2016 - 3 ) .

4.	INTANGIBLE FIXED ASSETS

Totals

£

COST

At 1 April 2016

90,690

Additions

55,481

At 31 March 2017

146,171

AMORTISATION

At 1 April 2016

6,444

Amortisation for year

10,939

At 31 March 2017

17,383

NET BOOK VALUE

At 31 March 2017

128,788

At 31 March 2016

84,246

5.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1 April 2016

8,030

Additions

4,949

At 31 March 2017

12,979

DEPRECIATION

At 1 April 2016

2,688

Charge for year

2,935

At 31 March 2017

5,623

NET BOOK VALUE

At 31 March 2017

7,356

At 31 March 2016

5,342

6.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2017

2016

value:

£

£

10,000

Ordinary

£1

10,000

10,000

7.	ULTIMATE CONTROLLING PARTY

The following reproduces the text of the report prepared for the directors in respect of the company's

annual unaudited financial statements. In accordance with the Companies Act 2006, the company is

only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain

other primary statements and the Report of the Directors are not required to be filed with the

Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval

the financial statements of Dermal Diagnostics Limited for the year ended 31 March 2017 which comprise the

Income Statement, Abridged Balance Sheet and the related notes from the company's accounting records

and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Dermal Diagnostics Limited, as a body, in accordance with the terms of our engagement letter dated 1 December 2017. Our work has been undertaken solely to prepare for your approval the financial statements of Dermal Diagnostics Limited and state those matters that we have agreed to state to the Board of Directors of Dermal Diagnostics Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Dermal Diagnostics Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Dermal Diagnostics Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Dermal Diagnostics Limited. You consider that Dermal Diagnostics Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Dermal Diagnostics Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

HSKS Greenhalgh

Chartered Accountants

18 St Christopher's Way

Pride Park

Derby

DE24 8JY

29 December 2017